NURS 345 - Nutrition for Disorders of the Liver, Gallbladder & Pancreas

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/60

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

61 Terms

1
New cards

viral hepatitis

inflammation of the liver caused by infectious mononucleosis, cirrhosis, toxic chemicals, and/or a viral infection

2
New cards

fecal-oral route

transmission of hepatitis A:

3
New cards

hepatitis A

type of hepatitis: often caused by poor hand washing or stool precautions. common in areas of poor sanitation

4
New cards

hepatitis A

type of hepatitis: vaccine available, recommended for people at risk

5
New cards

hepatitis A

type of hepatitis: rapid onset, within 4-6 weeks

6
New cards

hepatitis A and B

type of hepatitis: adequate diet without alcohol is recommended

7
New cards

through contaminated blood and sexual contact, and perinatally

transmission of hepatitis B:

8
New cards

hepatitis B

type of hepatitis: routine vaccination available for children and at-risk groups

9
New cards

hepatitis B

type of hepatitis: onset slow, approximately 12 weeks

10
New cards

through blood, saliva, or semen

transmission of hepatitis C:

11
New cards

hepatitis C

type of hepatitis: onset slow, approximately 8 weeks

12
New cards

10-40 years

progression from hepatitis C virus (HCV) to cirrhosis may take _____

13
New cards

hepatitis C and D

type of hepatitis: no dietary recommendations

14
New cards

hepatitis D

type of hepatitis: occurs only in an individual with hepatitis B virus coinfection or superinfection

15
New cards

hepatitis D

type of hepatitis: found throughout the world, but prevalent in Mediterranean basin, Middle East, Amazon basin, Samoa, China, Japan, Taiwan and Myanmar

16
New cards

hepatitis D

type of hepatitis: risk factor is intravenous drug use

17
New cards

intravenous drug use

risk factor of hepatitis D:

18
New cards

oral-fecal route

transmission of hepatitis E:

19
New cards

hepatitis E

type of hepatitis: risk factors are travel in tropical climates, inadequate sanitation, and poor personal hygiene

20
New cards

hepatitis E

type of hepatitis: avoid drinking water or other beverages that can be contaminated, avoid uncooked fruits and vegetables (!!!)

21
New cards

drinking water or other beverages that can be contaminated, uncooked fruits and vegetables

what should be avoided with hepatitis E?

22
New cards

initially liquid diet, then progress to small, frequent feedings high in calories and high in quality protein as tolerated

diet for patients with hepatitis:

23
New cards

steatorrhea

with hepatitis, fats should be limited only if _____ is present

24
New cards

B complex (especially thiamine and vitamin B12), vitamin K, vitamin C, and zinc

what vitamins should be supplemented with hepatitis?

25
New cards

nonalcoholic fatty liver disease (NAFLD)

the buildup of extra fat in the liver that is not caused by alcohol

26
New cards

nonalcoholic fatty liver disease (NAFLD)

highly prevalent (15-45%) in western societies

27
New cards

nonalcoholic fatty liver disease (NAFLD)

develops in people who are overweight or obese; who have diabetes, high cholesterol levels, elevated triglyceride levels, or poor eating habits; or who experience rapid weight loss

28
New cards

hepatic fibrosis

develops in 10-25% of cases of nonalcoholic fatty liver disease, and leads to cirrhosis, end-stage liver disease, or liver cancer

29
New cards

cirrhosis

caused by a buildup of fibrous connective tissue as a result of alcohol abuse, hepatitis, biliary disorders, chronic autoimmune diseases, metabolic disorders, or chronic use of hepatotoxic drugs

30
New cards

portal hypertension, esophageal varices, ascites, hepatic encephalopathy

complications of cirrhosis:

31
New cards

portal hypertension

complication of cirrhosis: increased pressure in portal vein

32
New cards

esophageal varices

complication of cirrhosis: enlarged blood vessels that bulge into the lumen of the esophagus

if ruptured, may be fatal

33
New cards

ascites

complication of cirrhosis: accumulation of fluid in the abdominal cavity

34
New cards

hepatic encephalopathy

complication of cirrhosis: brain damage resulting from toxic ammonia buildup

can result in hepatic coma

35
New cards

dietary restriction of sodium and sometimes fluids

treatment of ascites:

36
New cards

antibiotic therapy, lactulose, neomycin

treatment of hepatic encephalopathy:

37
New cards

using their DRY weight

how should the nurse calculate protein requirements for a patient with cirrhosis?

38
New cards

branched-chain amino acid based formula with restricted aromatic amino acids if protein sensitive

nutrition therapy for patients with hepatic encephalopathy from cirrhosis:

39
New cards

folate, vitamin B12, and thiamine

water soluble vitamins should be supplemented in patients with cirrhosis, with emphasis on _____

40
New cards

protein catabolism

patients with cirrhosis should eat foods high in kilocalories to prevent _____

41
New cards

enough kilocalories and protein to decrease protein catabolism and correct nutritional deficiencies

nutrition therapy before liver transplantation:

42
New cards

- total parenteral nutrition (TPN) or tube feeding may be necessary

- use ideal (desirable) weight rather than actual weight because of ascites, edema, or excess fluid

- kilocalories and protein must be adequate for hypercatabolic stresses

- provide between-meal feedings, supplements, or both

nutrition therapy 4-8 weeks after liver transplantation:

43
New cards

- eat a healthy, well-balanced diet

- prevent excessive weight gain, hypertension, hyperlipidemia, and diabetes

long-term nutrition therapy after liver transplantation:

44
New cards

- high-fat diet

- women: multiparity

- oral contraceptive or estrogen use

- obesity

- sedentary lifestyle

- rapid weight loss, very low-calorie diets

- older age

causes and predisposing factors of gallbladder disorders:

45
New cards

mild pain in mid-epigastrium after eating, colic attack (pain radiating to right upper quadrant and right subscapular area)

symptoms of cholelithiasis:

46
New cards

pain, tenderness, fever, fat intolerance, nausea, heartburn, jaundice, steatorrhea

symptoms of cholecystitis:

47
New cards

avoid foods that cause discomfort, follow low-fat diet

nutrition therapy for pain control for patients with gallbladder disorders:

48
New cards

start with clear liquids and progress to regular diet

postoperative nutrition therapy for patients with gallbladder disorders:

49
New cards

low-fat diet, individual tolerances vary

diet for patients with gallbladder disorders:

50
New cards

pancreatitis

inflammatory process characterized by decreased production of digestive enzymes and bicarbonate

51
New cards

excess alcohol consumption, gallbladder disease, or genetics

pancreatitis is caused by:

52
New cards

chronic pain, diabetes mellitus

consequences of pancreatitis:

53
New cards

autodigestion of the pancreas by enzymes, severe pain and elevated serum enzyme levels, malabsorption of fats and proteins

symptoms and complications of pancreatitis:

54
New cards

pancreatitis

affected patients may be malnourished because of protein and fat malabsorption → nutritional support is needed

55
New cards

minimize pancreatic secretions

the goal of nutrition therapy for patients with pancreatitis is to:

56
New cards

low-fat elemental formula

when enteral feeding is appropriate for patients with pancreatitis , a _____ formula is recommended

57
New cards

jejunum

position of an enteral feeding tube for patients with pancreatitis should be positioned in the _____ to allow for feeding with minimal stimulation of the pancreas

58
New cards

peripheral parenteral nutrition (PPN)

type of parenteral nutrition that may be used in non-stressed individuals with pancreatitis who are on NPO status for less than 10 days

59
New cards

central parenteral nutrition (CPN)

type of parenteral nutrition that may be used for those patients with pancreatitis who are on NPO status longer than 5-7 days

60
New cards

pancreatitis

medium-chain triglyceride (MCT) oils may be used for patients with _____

61
New cards

enzyme replacement

may be necessary for patients with pancreatitis to control malabsorption